BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 38486750)

  • 1. Copper metabolism and cuproptosis in human malignancies: Unraveling the complex interplay for therapeutic insights.
    Abdullah KM; Kaushal JB; Takkar S; Sharma G; Alsafwani ZW; Pothuraju R; Batra SK; Siddiqui JA
    Heliyon; 2024 Mar; 10(5):e27496. PubMed ID: 38486750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Copper homeostasis and cuproptosis in health and disease.
    Chen L; Min J; Wang F
    Signal Transduct Target Ther; 2022 Nov; 7(1):378. PubMed ID: 36414625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Copper homeostasis and cuproptosis in cancer immunity and therapy.
    Liu WQ; Lin WR; Yan L; Xu WH; Yang J
    Immunol Rev; 2024 Jan; 321(1):211-227. PubMed ID: 37715546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging insights into cuproptosis and copper metabolism: implications for age-related diseases and potential therapeutic strategies.
    Fan H; Wang K; Zhao X; Song B; Yao T; Liu T; Gao G; Lu W; Liu C
    Front Aging Neurosci; 2024; 16():1335122. PubMed ID: 38715962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Copper Metabolism and Cuproptosis: Molecular Mechanisms and Therapeutic Perspectives in Neurodegenerative Diseases.
    Ban XX; Wan H; Wan XX; Tan YT; Hu XM; Ban HX; Chen XY; Huang K; Zhang Q; Xiong K
    Curr Med Sci; 2024 Feb; 44(1):28-50. PubMed ID: 38336987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Copper homeostasis and cuproptosis in mitochondria.
    Tian Z; Jiang S; Zhou J; Zhang W
    Life Sci; 2023 Dec; 334():122223. PubMed ID: 38084674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cuproptosis: unveiling a new frontier in cancer biology and therapeutics.
    Feng Y; Yang Z; Wang J; Zhao H
    Cell Commun Signal; 2024 May; 22(1):249. PubMed ID: 38693584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cuproptosis: Mechanism, role, and advances in urological malignancies.
    Wu J; He J; Liu Z; Zhu X; Li Z; Chen A; Lu J
    Med Res Rev; 2024 Jul; 44(4):1662-1682. PubMed ID: 38299968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cuproptosis, the novel therapeutic mechanism for heart failure: a narrative review.
    Yuan HJ; Xue YT; Liu Y
    Cardiovasc Diagn Ther; 2022 Oct; 12(5):681-692. PubMed ID: 36329965
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms of cuproptosis and its relevance to distinct diseases.
    Lou QM; Lai FF; Li JW; Mao KJ; Wan HT; He Y
    Apoptosis; 2024 Jun; ():. PubMed ID: 38824478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cuproptosis: p53-regulated metabolic cell death?
    Xiong C; Ling H; Hao Q; Zhou X
    Cell Death Differ; 2023 Apr; 30(4):876-884. PubMed ID: 36755067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cuproptosis as the new kryptonite of cancer: a copper-dependent novel cell death mechanism with promising implications for the treatment of hepatocellular carcinoma.
    Ozkan E; Bakar-Ates F
    J Cancer Res Clin Oncol; 2023 Dec; 149(19):17663-17670. PubMed ID: 37843555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cuproptosis-a potential target for the treatment of osteoporosis.
    Li D; Gao Z; Li Q; Liu X; Liu H
    Front Endocrinol (Lausanne); 2023; 14():1135181. PubMed ID: 37214253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The mechanism of cuproptosis in Parkinson's disease.
    Huang M; Zhang Y; Liu X
    Ageing Res Rev; 2024 Mar; 95():102214. PubMed ID: 38311254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis in lung cancer: therapeutic options and prognostic models.
    Jawed R; Bhatti H
    Apoptosis; 2024 May; ():. PubMed ID: 38735011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exploring cuproptosis as a mechanism and potential intervention target in cardiovascular diseases.
    Yang Y; Feng Q; Luan Y; Liu H; Jiao Y; Hao H; Yu B; Luan Y; Ren K
    Front Pharmacol; 2023; 14():1229297. PubMed ID: 37637426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial-Targeted Copper Delivery for Cuproptosis-Based Synergistic Cancer Therapy.
    Deng J; Zhuang H; Shao S; Zeng X; Xue P; Bai T; Wang X; Shangguan S; Chen Y; Yan S; Huang W
    Adv Healthc Mater; 2024 Mar; ():e2304522. PubMed ID: 38530073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein lipoylation: mitochondria, cuproptosis, and beyond.
    Lin CH; Chin Y; Zhou M; Sobol RW; Hung MC; Tan M
    Trends Biochem Sci; 2024 May; ():. PubMed ID: 38714376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Copper homeostasis and cuproptosis in gynecological disorders: Pathogenic insights and therapeutic implications.
    Lin Y; Yuan M; Wang G
    J Trace Elem Med Biol; 2024 Jul; 84():127436. PubMed ID: 38547725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cuproptosis: Harnessing Transition Metal for Cancer Therapy.
    Wang W; Mo W; Hang Z; Huang Y; Yi H; Sun Z; Lei A
    ACS Nano; 2023 Oct; 17(20):19581-19599. PubMed ID: 37820312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.